chitosan has been researched along with Cardiomyopathies, Primary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, W; Han, X; Huang, L; Ji, H; Li, X; Li, Z; Liu, C; Man, S; Pecoraro, L; Qiao, O; Wang, J; Wang, W; Zhang, X; Zhang, Y | 1 |
| Abe, T; Chanda, J; Kuribayashi, R | 1 |
2 other study(ies) available for chitosan and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Nanoparticle conjugation of ginsenoside Rb3 inhibits myocardial fibrosis by regulating PPARĪ± pathway.
Topics: Animals; Biological Availability; Cardiomyopathies; Chitosan; Drug Carriers; Drug Compounding; Energy Metabolism; Fibrosis; Ginsenosides; Male; Molecular Docking Simulation; Myocardium; Nanoparticles; Panax; Polyphosphates; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction | 2021 |
Use of the glutaraldehyde-chitosan-treated porcine pericardium as a pericardial substitute.
Topics: Animals; Calcinosis; Cardiac Surgical Procedures; Cardiomyopathies; Chitin; Chitosan; Dogs; Glutaral; Pericardium; Swine; Tissue Adhesions | 1996 |